Dr Costas O’Mahony is a consultant cardiologist based at the Centre for Inherited Cardiovascular Disease Unit at St Bartholomew’s Hospital in London UK and leads the alcohol septal ablation programme. He studied medicine at Imperial College London and graduated with a first-class BSc(Hons) in immunology in 1998 and with distinction in medicine in 2001. He is a fellow of the Royal College of Physicians. Dr O’Mahony was awarded an MD(Res) by University College London for research in sudden cardiac death in hypertrophic cardiomyopathy. He contributed to the 2014 ESC guidelines on the diagnosis and management of hypertrophic cardiomyopathy and led the development and validation of a risk prediction model for sudden cardiac death in HCM (HCM Risk-SCD). He is an honorary associate professor at the Institute of Cardiovascular Science at University College London and his current research is focused on clinical outcomes in cardiomyopathies and stereotactic radiotherapy for the treatment of symptomatic left ventricular outflow tract obstruction. Dr O’Mahony runs a specialist cardiomyopathy clinic and performs invasive haemodynamic assessments, cardiac biopsies, alcohol septal ablation and percutaneous coronary intervention.

Professor Paul Bannon is the Chairman of the Baird Institute for Applied Heart and Lung Surgical Research, a not-for-profit medical research institute established in 2001, to improve the outcomes and better the lives of those undergoing heart and lung surgery. He is a Visiting Medical Officer of Cardiothoracic Surgery at Royal Prince Alfred Hospital, Sydney and holds the Chair of Cardiothoracic Surgery and the Bosch Chair of Surgery, University of Sydney.

Professor Diane Fatkin trained in Clinical Cardiology and Molecular Genetics and is currently Head of the Sr Bernice Research Program in Inherited Heart Diseases, in the Molecular Cardiology Division of the Victor Chang Cardiac Research Institute, Sydney. She also holds appointments as Honorary Medical Officer in the Cardiology Department, St Vincent’s Hospital, and Professor (conjoint) in the Faculty of Medicine, UNSW Sydney. Her research is focused on understanding the molecular genetic basis of inherited cardiomyopathies, with a specific interest in familial dilated cardiomyopathy and familial atrial fibrillation. This work spans from clinical and genetics studies in families with inherited cardiomyopathies, to functional genomics in cell, mouse, and zebrafish models. A major objective of the team’s research is “bench-to-bedside” translation of new insights about disease mechanisms into personalised approaches to patient management.

Dr Pantazis has many years of experience working within the field of cardiomyopathies and is currently working out of Royal Brompton and Harefield Hospitals. He was first appointed as a consultant cardiologist at the Heart Hospital, University College London Hospitals NHS Foundation Trust (UCLH), in 2007, and then went on to work as a consultant cardiologist at Barts Heart Centre at St Bartholomew’s Hospital, London, in May 2015. He was the leading cardiologist at UCLH’s neuromuscular complex care centre (NMCCC) in the National Hospital for Neurology and Neurosurgery. He was also the leading cardiologist for the interventional and surgical programmes for the management of left-ventricular outflow tract obstruction (LVOTO) in hypertrophic cardiomyopathy.

A/Prof Jodie Ingles is Head of the Clinical Genomics Laboratory and Director of Genomics and Inherited Disease Program, Garvan Institute of Medical Research. She is a cardiac genetic counsellor in the Department of Cardiology, Royal Prince Alfred Hospital.

Hitesh is the Head of Heart Failure and Transplant at the Alfred. He is one of the senior device implanters. He is part of the Cardio-Genetics clinic.